Table 3c:

Risks of developing t-MN after autotransplant for NHL (n=3540)

Parameter	n	Hazard Ratio (95% CI)	P-value
Age at transplant, years			<.01
18-44	748	1.00
45-54	938	2.77(1.55 - 4.93)	<.01
55+	1854	4.52(2.63 - 7.77)	<.01
No. of prior lines of chemotherapy			<.01
1	846	1.00
2	1422	0.98(0.67 - 1.44)	0.91
3+	1128	1.93(1.34 - 2.78)	<.01
Missing	144	0.55(0.20 - 1.53)	0.25
Conditioning			0.04
BEAM or similar	2316	1.00
TBI based	510	1.69(1.14 - 2.49)	0.008
CBV or similar	381	0.96(0.59 - 1.54)	0.86
Bu+Mel/Bu+Cy	197	1.75(1.03 - 2.96)	0.04
Others	136	1.30(0.60 - 2.82)	0.51
Year of transplant			<.01
1995-1999	1350	1.00
2000-2004	735	1.36 (0.91 - 2.05)	0.14
2005-2010	1455	2.12 (1.47 - 3.08)	<.01